TY  - JOUR
T1  - Streptokinase Loaded Solid Lipid Nanoparticles: Preparation and Charactrization
A1  - Hediyeh Rassam
A1  - Abdolamir Allameh
A1  - Akram Eidi
A1  - Mahmoud Alebouyeh
A1  - Delaram Doroud
JF  - Archives of Pharmacy Practice
JO  - Arch Pharm Pract
SN  - 2320-5210
Y1  - 2019
VL  - 10
IS  - 4
SP  - 178
EP  - 187
N2  - Thrombolytic therapy for acute myocardial infarction consists of recombinant streptokinase (rSK) or tissue plasminogen activator (tPA) and other similar enzymes. In this study, the potential of solid lipid nanoparticles (SLN) as nano-protein carriers of thrombolytic agents was investigated. SLN formulation for utilization in targeted enzymatic delivery of rSK was prepared using a combined technique. Response surface methodology (RSM) was employed to develop the best formulation and analyze the effect of different parameters on the efficient of the SLN-rSK formulation. The optimum condition of the formulation for SLN-rSK preparation was found to be at lipid concentration 0.5 mg/ml, surfactants ratio of 0.5, rSK concentration 4 mg/ml, hgomogenization time 20 min and speed 20000 rpm. The formulation characterization analyzed by SEM method showed that SLN-rSK formulation has a spiral appearance. The size of formulation was determined with DLS (
UR  - https://archivepp.com/article/streptokinase-loaded-solid-lipid-nanoparticles-preparation-and-charactrization
ER  -